MAPT and Alzheimer disease: We found that fibrinogen levels in AD patients had significantly positive correlation with CSF t-tau/Aβ42 levels (γ = 0.524, p = 0.002) and p-tau/Aβ42 levels (γ = 0.427, p = 0.013).